newsfilter
← Latest News
GlobeNewswire·

Aerovate Therapeutics Announces Second Quarter 2022 Financial Results

WALTHAM, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (NASDAQ:AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today